Le Lézard
Classified in: Health, Science and technology
Subject: ANNUAL MEETINGS

Zenith Announces Annual and Special Meeting of Shareholders


CALGARY, Alberta, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith") announced today that its Annual and Special Meeting of Shareholders (the "Meeting") is to be held Thursday, October 31, 2019 at Mount Royal University, Roderick Mah Centre for Continuous Learning ? Ross Glen Hall (Room EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta.

A Notice of Meeting and Management Information Circular, containing further details including matters to be considered at the Meeting and the start time, will be delivered to shareholders and filed on SEDAR at www.sedar.com on or about Monday, September 30, 2019.

Following the formal business of the Meeting, Donald McCaffrey, President and Chief Executive Officer, will provide a corporate update presentation.

About Zenith

Zenith Capital Corp. is a biotechnology investment company originally spun out of Resverlogix Corp. (TSX: RVX) in 2013. Zenith Epigenetics Ltd., a wholly-owned subsidiary of Zenith Capital Corp., is a clinical stage biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other disorders with significant unmet medical need. Zenith Epigenetics is developing various novel combinations of BET inhibitors with other targeted agents. The lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer ("mCRPC") and Triple Negative Breast Cancer.

For further information, please contact:

Investor Relations & Communications
Phone : 587-390-7865
Email : info@zenithepigenetics.com
Website : www.zenithepigenetics.com
           

                                                           
                                                                       



These press releases may also interest you

at 00:01
Osteoporosis is often called a silent disease that is largely preventable, yet it affects approximately 54 million Americans.i Despite the modifiable lifestyle choices people can take to prevent osteoporosis-related fractures, they continue to rise,...

at 00:00
On November 2, 2019, Smart Kids with Learning Disabilities will host the 3rd Annual Fall Parenting Conference: Rising to the Challenge at Winston Preparatory School in Norwalk, CT. The conference will provide parents of children with learning...

at 00:00
Labeling for Prescription Drugs, Biologics and Combination Products: Complying with FDA's Most Recent IFU Guidance **An FDAnews Webinar** Tuesday, October 29, 2019, 1:30-3:00 p.m. EDT https://www.fdanews.com/labelpredrug What implications does the...

at 00:00
Today, at the 2019 World Cancer Leaders' Summit in Nur-Sultan (Astana), Kazakhstan, it was announced that the Malaysian city of Greater Petaling is joining City Cancer Challenge (C/Can). The...

14 oct 2019
The AASCP delegates from the United States traveled to the Bahamas to discuss medical industry safety standards. The AASCP attended an event organized by Dr. Desiree Cox, who is the CEO of The HEALinc Innovation Incubator and the HEALinc Future...

14 oct 2019
BioMed Realty, a leading provider of real estate solutions for the life science industry, announced today that it has executed a 12-year lease with Zymergen for 300,000 square feet at Emeryville Center of Innovation. BioMed Realty will invest capital...



News published on 22 august 2019 at 17:25 and distributed by: